| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |